Genomembrane Co., Ltd. was established as a bio-tech venture company by a group of scientists in April, 2002. GenoMembrane aim to provide transporter-related products and services that will be useful in the development and design of novel drugs for clinical application.
GenoMembrane provides research tools and collaborates for the pharmacological evaluation of drug candidates in order to lessen cost and help advance the success rate of candidate drugs, and speed up new drug development.
GenoMembrane distributes our new products information including the latest news to customers by e-mail. If you have any questions or want to subscribe our news letter, please send a message to:
* GenoMembrane will only collect your personal information by appropriate and fair means and will not use your personal information beyond the scope of the purpose of use.